Two new conditions have been added to the list of medical issues that qualify Illinois residents for the state’s Medical Cannabis Patient Program, health officials announced Tuesday.
Illinois Department of Public Health Director Dr. Sameer Vohra approved the additions of sickle cell disease and polyendocrine metabolic ovarian syndrome with chronic pain.
Under state law, the IDPH director reviews public petition requests to expand the approved list of “debilitating medical conditions” based on scientific analysis and medical literature.
“Medical cannabis can provide relief for people living with certain debilitating conditions,” Vohra said. “We look forward to working with our medical providers to ensure safe, appropriate access for individuals struggling with these newly approved conditions,” he added.
